Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
NCT00859677 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2023-02-15
Summary
The purpose of this study is to investigate the role of T helper 17 cells (Th17) in the pathogenesis of MRSA infections.
Conditions
- HIV Infections
- Staphylococcal Infections
Sponsors & Collaborators
-
Infectious Diseases Clinical Research Program
collaborator OTHER -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Henry M. Jackson Foundation for the Advancement of Military Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2010-11-30
- Completion
- 2016-08-26
Countries
- United States
Study Locations
More Related Trials
-
Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
NCT01895920 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00080106 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
NCT00183261 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load
NCT00025922 ·Status: COMPLETED
-
Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
NCT00955006 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Vaccine for HIV
NCT01859325 ·Status: COMPLETED ·Phase: PHASE1
-
Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
NCT00001046 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
NCT00125099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
NCT00099671 ·Status: COMPLETED ·Phase: PHASE1
-
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV
NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
NCT05769569 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
NCT00833781 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Analysis of Immune Responses to HIV Vaccines
NCT00068978 ·Status: COMPLETED
-
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection
NCT04505501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
NCT00000822 ·Status: COMPLETED ·Phase: PHASE1
-
Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
NCT02886416 ·Status: COMPLETED
-
Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
NCT01969058 ·Status: COMPLETED ·Phase: PHASE2
-
HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals
NCT03485963 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000756 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
NCT01376726 ·Status: COMPLETED ·Phase: PHASE1
-
A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a
NCT03298360 ·Status: COMPLETED
-
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00058734 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response to Influenza Vaccine in HIV-Infected Individuals
NCT00069914 ·Status: COMPLETED
-
Perturbing of HIV Reservoir With Immune Stimulation
NCT02707692 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
NCT00996970 ·Status: COMPLETED